Composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid and tomato extract

A technology of tomato extract and compound preparation, which is applied in compound preparation, compound preparation for treating cardiovascular diseases and prostate diseases, has the field of preventive health care, and can solve problems such as loss of phospholipid activity.

Inactive Publication Date: 2011-04-20
SHANGHAI TAILORED BIOLOGICAL TECH
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the activity of phospholipids is most effective at about 25 degrees Celsius, and wh...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid and tomato extract
  • Composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid and tomato extract
  • Composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid and tomato extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The present invention is made from the raw material of following percentage by weight:

[0037] Alpha-Linolenic Acid 10%

[0038] Phospholipids 45%

[0039] Gamma Linolenic Acid 5%

[0040] Tomato Extract 10%

[0041] The rest are common preparation excipients

[0042] After the above-mentioned raw materials are mixed according to the ratio, soft capsules are prepared according to the production process of soft capsule preparations.

[0043] The α-linolenic acid raw material is linseed oil, the phospholipid raw material is egg yolk lecithin, the gamma-linolenic acid raw material is amaranth oil, and the content of lycopene in the tomato extract is 6%.

Embodiment 2

[0045] The present invention is made from the raw material of following percentage by weight:

[0046] Alpha-Linolenic Acid 15%

[0047] Phospholipids 50%

[0048] Gamma Linolenic Acid 3%

[0049] Tomato Extract 15%

[0050] Phytosterols 10%

[0051] The rest are common preparation excipients

[0052] After the above-mentioned raw materials are mixed according to the ratio, the dropping pills are prepared according to the production process of the dropping pill preparations.

[0053] The α-linolenic acid raw material is perilla oil, the phospholipid raw material is soybean lecithin, the gamma-linolenic acid raw material is amaranth oil, and the content of lycopene in the tomato extract is 30%.

Embodiment 3

[0055] The present invention is made from the raw material of following percentage by weight:

[0056] Alpha-Linolenic Acid 18%

[0057] Phospholipids 60%

[0058] Gamma-Linolenic Acid 1%

[0059] Tomato Extract 15%

[0060] Phytosterols 3%

[0061] VC 1%

[0062] VE 1%

[0063] The rest are common preparation excipients

[0064] After the above-mentioned raw materials are mixed according to the ratio, the dropping pills are prepared according to the production process of the dropping pill preparations.

[0065] The α-linolenic acid raw material is perilla oil, the phospholipid raw material is soybean lecithin, the gamma-linolenic acid raw material is amaranth oil, and the lycopene content in the tomato extract is 20%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid, tomato extract, phytosterol, etc. The composite preparation can be used to prepare health food, medicine and functional food that have the functions of treatment and prevention to cardiovascular diseases and prostate diseases, the alleviation of age-related awareness decrudescence, the improvement of memory, the relief of cerebral fatigue, the alleviation of mental pressure, and the improvement of childhood hyperkinetic syndrome. The composite preparation can be prepared into dosage forms of soft capsules, dropping pills, etc. which are convenient in administration and easy to popularization.

Description

technical field [0001] The invention belongs to a compound preparation in the field of health care medicine, and in particular relates to a compound formula preparation for prevention and health care, and treatment of cardiovascular diseases and prostate diseases. Background technique [0002] Nearly a quarter of the world's population is threatened by cardiovascular and related diseases, and throughout their lives, one-third of people may be shrouded in the shadow of cardiovascular diseases in their lives, and finally one-fifth of the population dies of cardiovascular diseases. Vascular-related diseases. With the improvement of people's living standards and population aging, more and more diseases such as hyperlipidemia and high blood pressure continue to increase. Therefore, the struggle against cardiovascular diseases has become Be one of the challenges of all humanity. [0003] Prostate disease is a common and frequently-occurring disease of the urinary system in middle...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/81A61K9/20A61K9/48A61P9/00A61P13/08A61P25/28A61P25/00A23L1/29A61K31/202A61K31/56A61K31/575A61K31/683A61K31/685A61K31/688A61K31/375A61K31/355A61K35/64A61K131/00A23L33/00A61K35/644
Inventor 赵鲁松
Owner SHANGHAI TAILORED BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap